Print Page  Close Window

2015 News Releases
Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
02/26/15Kindred Healthcare Board of Directors Declares Quarterly Cash Dividend of $0.12 Per Common Share and Approves Scheduled Installment Payment on 7.50% Tangible Equity Units
LOUISVILLE, Ky.--(BUSINESS WIRE)--Feb. 26, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that its Board of Directors approved the payment of the regular quarterly cash dividend to its common shareholders. The quarterly cash dividend of $0.12 per common share will be paid on April 1, 2015 to shareholders of record as of the close of business on March 11, 2015. Kindred also today announced that its B... 
Printer Friendly Version
02/26/15Kindred Healthcare Announces Fourth Quarter 2014 Results
Core Diluted EPS from Continuing Operations of $0.26(1) in the Fourth Quarter and $1.06(1) for the Year GAAP Loss Per Share from Continuing Operations of $0.15 for the Fourth Quarter and $0.24 for the Year Concludes Solid Year with 6% Growth in Consolidated Revenues and 9% Growth in Core Operating Income for the Fourth Quarter and 5% Growth in both Consolidated Revenues and Core Operating Income for the Year --------... 
Printer Friendly Version
02/17/15Kindred’s Fourth Quarter Conference Call Scheduled for February 27
LOUISVILLE, Ky.--(BUSINESS WIRE)--Feb. 17, 2015-- Kindred Healthcare, Inc. (the “Company”) (NYSE:KND) announced today that it will provide an online, real-time webcast of its conference call covering fourth quarter and year-end 2014 operating results on Friday, February 27, 2015. The Company will issue its fourth quarter and year-end 2014 earnings release after the close of trading on Thursday, February 26, 2015. The live broadcast of the ... 
Printer Friendly Version
02/11/15Kindred Names Dr. Marc Rothman Senior Chief Medical Officer
LOUISVILLE, Ky.--(BUSINESS WIRE)--Feb. 11, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced the promotion of Dr. Marc Rothman to Senior Vice President and Senior Chief Medical Officer for the Company, effective immediately. In this capacity Dr. Rothman will oversee the Company’s physician strategy, lead Kindred’s executive physician team, and drive physician network development and recruitment across divisions and s... 
Printer Friendly Version
02/02/15Kindred Healthcare Completes Acquisition of Gentiva Health Services Creating Nation-Wide Integrated Care Delivery System
Combined Company Will Have Pro Forma Annual Revenues of Approximately $7.2 Billion1 and Operating Income of More Than $1.0 Billion1 Transaction Will be Immediately and Significantly Accretive to Kindred Earnings and Cash Flows2, with More Than $70 Million of Expected Synergies, Accelerating Kindred’s Growth and Margin Profile LOUISVILLE, Ky.--(BUSINESS WIRE)--Feb. 2, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (... 
Printer Friendly Version
01/30/15Kindred Healthcare Announces Receipt of Consents to Amend Indenture
LOUISVILLE, Ky.--(BUSINESS WIRE)--Jan. 30, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today reported the results of its previously announced solicitation of consents (the “Solicitation”) to certain proposed amendments (the “Amendments”) to the indenture, dated as of April 9, 2014 (the “Indenture”), governing the Company’s 6.375% Senior Notes due 2022 (the “2022 Notes”), CUSIP 494580 AC7 (Rule 144A) and U4946LAA7 (Regulation ... 
Printer Friendly Version
01/29/15Kindred Healthcare Announces Results of the Exchange Offer for Its 6.375% Senior Notes Due 2022
LOUISVILLE, Ky.--(BUSINESS WIRE)--Jan. 29, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced the final results of its registered exchange offer (the “Exchange Offer”) for all of its outstanding 6.375% Senior Notes due 2022 (the “Initial Notes”), which were not registered under the Securities Act of 1933, as amended (the “Securities Act”), for an equal principal amount of its 6.375% Senior Notes due 2022, which have b... 
Printer Friendly Version
01/28/15Kindred Healthcare Extends Expiration Date in Consent Solicitation
LOUISVILLE, Ky.--(BUSINESS WIRE)--Jan. 28, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that it has extended the expiration time for its previously announced solicitation of consents (the “Solicitation”) to certain proposed amendments to the indenture, dated as of April 9, 2014, governing the Company’s 6.375% Senior Notes due 2022, CUSIP 494580 AC7 (Rule 144A) and U4946LAA7 (Regulation S), pursuant to its Consen... 
Printer Friendly Version
01/28/15Kindred Healthcare Extends Expiration Date and Increases Cash Consent Payment in Consent Solicitation
LOUISVILLE, Ky.--(BUSINESS WIRE)--Jan. 28, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that it has extended the expiration time and increased the cash consent payment for its previously announced solicitation of consents (the “Solicitation”) to certain proposed amendments to the indenture, dated as of April 9, 2014 (the “Indenture”), governing the Company’s 6.375% Senior Notes due 2022 (the “2022 Notes”), CUSIP... 
Printer Friendly Version
01/26/15Kindred Names Kent H. Wallace Executive Vice President and Chief Operating Officer
LOUISVILLE, Ky.--(BUSINESS WIRE)--Jan. 26, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that it has named Kent H. Wallace Executive Vice President and Chief Operating Officer, effective February 2, 2015. Mr. Wallace will be a member of the Company’s Executive Committee. Mr. Wallace will report to Benjamin A. Breier, President and Chief Operating Officer. Kindred previously announced that Mr. Breier will ... 
Printer Friendly Version
01/22/15Kindred Healthcare Announces Gentiva Health Services Stockholder Approval of Combination
Transaction Expected to Close on February 2, 2015 LOUISVILLE, Ky.--(BUSINESS WIRE)--Jan. 22, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) announced that, at the Special Meeting of Stockholders of Gentiva Health Services, Inc. (“Gentiva”) (NASDAQ:GTIV) held today, the Gentiva stockholders approved Gentiva’s combination with Kindred. As previously announced on October 9, 2014, Kindred and Gentiva entered into a... 
Printer Friendly Version
01/15/15Kindred Healthcare Commences Consent Solicitation to Amend Indenture
LOUISVILLE, Ky.--(BUSINESS WIRE)--Jan. 15, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that it has commenced soliciting consents to certain proposed amendments to the indenture, dated as of April 9, 2014 (the “Indenture”), governing the Company’s 6.375% Senior Notes due 2022 (the “2022 Notes”), CUSIP 494580 AC7 (Rule 144A) and U4946LAA7 (Regulation S), pursuant to a Consent Solicitation Statement, dated as of J... 
Printer Friendly Version
01/07/15Kindred to Present at the J.P. Morgan Healthcare Conference
LOUISVILLE, Ky.--(BUSINESS WIRE)--Jan. 7, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that Benjamin A. Breier, President and Chief Operating Officer, will make a presentation regarding the Company at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Wednesday, January 14, 2015, at 9:30 a.m. Pacific Time / 12:30 p.m. Eastern Time. The presentation is being audio we... 
Printer Friendly Version
01/02/15Kindred Acquires Centerre Healthcare
Creates One of Nation’s Largest Networks of Inpatient Rehabilitation Hospitals and Significantly Expands Kindred’s Continuum of Services Kindred Establishes New Growth Platform, Kindred Hospital Rehabilitation Services LOUISVILLE, Ky.--(BUSINESS WIRE)--Jan. 2, 2015-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that it has completed the previously announced acquisition of Centerre Heal... 
Printer Friendly Version